
Kamada Ltd. KMDA
$ 7.82
-2.62%
Quarterly report 2025-Q4
added 05-06-2026
Kamada Ltd. P/S Ratio 2011-2026 | KMDA
Annual P/S Ratio Kamada Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.72 | 2.56 | 2.09 | 2.01 | 2.61 | 2.13 | 2.07 | 1.85 | 2.01 | 2.87 | 1.92 | 2.04 | 7.01 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.01 | 1.85 | 2.61 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
0.429 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.73 | $ 16.96 | -1.97 % | $ 793 M | ||
|
AgeX Therapeutics
AGE
|
9.24 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.77 | -8.75 % | $ 259 M | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
2.13 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 7.46 | -4.73 % | $ 204 M | ||
|
Midatech Pharma plc
MTP
|
240 | - | -18.52 % | $ 27.3 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 4.07 | -7.5 % | $ 1.22 B | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.57 | -3.99 % | $ 184 M | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.59 | -0.31 % | $ 423 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
BioNTech SE
BNTX
|
35.7 | $ 89.2 | -3.03 % | $ 21.6 B | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
11.9 | $ 3.36 | -3.72 % | $ 5.53 M | ||
|
Aeterna Zentaris
AEZS
|
1.54 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Eton Pharmaceuticals
ETON
|
6.99 | $ 29.97 | 0.03 % | $ 806 M | ||
|
Esperion Therapeutics
ESPR
|
1.39 | $ 3.13 | 0.16 % | $ 651 M | ||
|
Exelixis
EXEL
|
5.05 | $ 50.06 | -2.04 % | $ 13.6 B | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 21.73 | 0.74 % | $ 2.76 B | ||
|
Fortress Biotech
FBIO
|
1.23 | $ 2.37 | 2.83 % | $ 66.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Forte Biosciences
FBRX
|
181 | $ 22.45 | -6.3 % | $ 291 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Fennec Pharmaceuticals
FENC
|
3.78 | $ 9.83 | 6.39 % | $ 281 M |